The Platform and expert system for genomic studies, MEDIGENOMICS, pursues the design, construction and development of a unique, integrated and expert service that combines the entire process of genomic studies of an individual (DNA/RNA extraction, nucleic acid sequence analysis, file generation, analysis and interpretation of results, and real-time information) on a single platform.
The service simplifies and automates the analysis of mass genome, exome, or gene panel sequencing done automatically on a centralised device.
Combining the entire sequencing analysis process on a single platform would improve diagnostic efficiency and effectiveness, cutting down on time and sample handling.
An innovative computerised platform could analyse, compile and store genomic information of healthy/ill individuals, with the unprecedented possibility of being kept up to date in a database as knowledge and information emerge in the medical literature.
The project has a total budget for Phase I of €2.5 million (R&D&I Phase), under the collaboration agreement signed by the Ministry of Health of the Community of Madrid and the Ministry of Science and Innovation in December 2020, within the framework of the Line of Promotion of Demand-Side Innovation (FID) of the third call for proposals) to promote the Public Procurement of Innovation (PPI) in health services.
MEDIGENOMICSis 50% co-financed by the European Regional Development Fund (ERDF),through a grant awarded by the Ministry of Science and Innovation,which is part of the Pluri-Regional Operational Programme of Spain (POPE) 2014-2020. It reinforces the Community of Madrid’s commitment to this instrument to continue modernising the Administration and It also favours business competitiveness and strengthens public-private collaboration.
This project will run from 25 September 2019 through 30 June 2023.
The added value of this project can be summarised as follows
Public health impact: